SCHOTT Pharma AG & Co KgaA

SCHOTT Pharma AG & Co's GHG Emissions Data Preview

In 2023, SCHOTT Pharma AG & Co completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

However, SCHOTT Pharma AG & Co has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)	2023	2022	2021	2020 - 2017
Total Scope 1 Total direct GHG emissions from categories that are owned or directly controlled by the company.	Copy restricted. Please purchase to unlock this data. a	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data.	Data available for purchase 0000000
Total Scope 2 Indirect GHG emissions from the generation of purchased electricity, steam, heating, and cooling consumed by the reporting company.
Market-Based Indirect emissions from purchased energy calculated using the market-based method, which reflects contractual instruments such as supplier-specific emission factors or renewable energy certificates (RECs).	Copy restricted. Please purchase to unlock this data. a	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data.	Data available for purchase 0000000
Location-Based Indirect emissions from purchased energy calculated using the location-based method, which reflects average emission factors of the local grid.	Copy restricted. Please purchase to unlock this data. a	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data.	Data available for purchase 0000000
Total Scope 3 All other indirect GHG emissions that occur in the company’s value chain, outside of Scope 1 and 2. This includes both upstream and downstream activities.	Copy restricted. Please purchase to unlock this data. a	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data.	Data available for purchase 0000000

Download Data

Download SCHOTT Pharma AG & Co's GHG Emissions data for free

Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.

Sign Up

Insights into SCHOTT Pharma AG & Co's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of SCHOTT Pharma AG & Co amounted to 73,813 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). ^a

Insights into SCHOTT Pharma AG & Co's Value Chain Emissions

In 2023, SCHOTT Pharma AG & Co reported 532 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. ^a

The 2023 disclosure of SCHOTT Pharma AG & Co includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in , demonstrating consistent Scope 3 emissions reporting coverage year over year. ^a

Insights into SCHOTT Pharma AG & Co's Total Carbon Footprint

In 2023, SCHOTT Pharma AG & Co reported a total carbon footprint of 74,345 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. ^a

The largest contributor to SCHOTT Pharma AG & Co's total carbon footprint was Scope 2 emissions, accounting for 58.63% of the company's total carbon footprint, followed by Scope 1 emissions at 40.66%. ^a